Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2022-02-21 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MAJOR TRANSACTION ACQUISITION OF 58.2% EQUITY INTEREST IN THE TARGET COMPANY AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by PW Medtech Group Limited regarding a major transaction involving the acquisition of a 58.2% equity interest in a target company. It includes detailed information such as a letter from the board, financial information, accountants' report, management discussion and analysis, valuation report, profit forecast letters, general information, and a notice of an extraordinary general meeting (EGM). The document is comprehensive and lengthy (15,000 characters), containing substantive financial and transactional details. It is not merely an announcement or a proxy solicitation but a detailed circular providing information to shareholders about a major transaction and the related EGM. This type of document aligns with the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings, especially in the context of major transactions and EGMs.
2022-02-21 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a further delay in the despatch of a circular related to an acquisition and share transfer/subscription agreements. It references previous announcements and states the new expected despatch date for the circular. The document is short (2018 characters) and does not contain any financial statements or detailed report content. It is clearly an announcement about the timing of a report (the circular) rather than the report itself. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement about procedural updates, not a full report or financial disclosure.
2022-02-18 English
CONNECTED TRANSACTION - APPLICATION FOR SHARES IN THE IPO OF LEPU BIOPHARMA CO., LTD.
Capital/Financing Update Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding its application to subscribe for shares in the IPO of Lepu Biopharma Co., Ltd. It details the transaction, the relationship between the parties, the financial information of Lepu Biopharma, and the regulatory implications under the Listing Rules. The document is not a full financial report, earnings release, or management discussion, but rather an announcement of a connected transaction related to capital investment. It does not contain financial statements or detailed financial analysis but focuses on the transaction and its compliance with listing rules. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-02-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for PW Medtech Group Limited. It details movements in authorized and issued share capital, share options, repurchases, and confirmations related to securities issued. The document is regulatory in nature, providing updates on share capital and share movements rather than a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a proxy solicitation, nor a capital raising update. It is a regulatory filing required under the Exchange Listing Rules, specifically a monthly return on share capital movements. The document length and content indicate it is a substantive regulatory filing rather than a brief announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-02-07 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data and confirmations. The content fits the category of Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2022-01-28 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a delay in the despatch of a circular related to an acquisition transaction. It references a previous announcement and states that the circular, which contains details of the Share Transfer Agreement, Share Subscription Agreement, and notice of an Extraordinary General Meeting (EGM), will be delayed. The document is short (1868 characters) and serves as a notification about the timing of a report (the circular) rather than the report itself. There is no financial data or detailed report content included. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the delay in sending a circular, not the circular or any other report itself.
2022-01-28 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.